Please Wait
Applying Filters...
menu
    • menu
    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Piramal Pharma Solutions

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    SERVICES

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    Alchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    micAlchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    With increasing flavour bans in key markets, vaping brands are facing significant challenges in providing satisfying alternatives to vapers and smokers looking to transition. Recognising this need, Alchem NicSelect™ is making a bold move by offering its key customers royalty-free and unrestricted geographical access to its revolutionary T-MAX™ technology.“At Alchem NicSelect™, we understand the urgency for vaping brands to adapt to new regulations without compromising on satisfaction. By offering royalty-free access to T-MAX™ technology, we empower our customers to provide the closest cigarette-like experience possible, even in markets with strict flavour restrictions,” said Riccardo Santambrogio, Europe Sales Manager.HIGHLIGHTS// offering royalty-free access to T-MAX™ technology/ unrestricted geographical access/ closest cigarette-like experience Addressing the biggest barrier: Nicotine satisfactionOne of the primary reasons many vapers are dissatisfied and smokers struggle to switch to vaping is that traditional nicotine solutions fail to replicate the rapid satisfaction provided by cigarettes. Nicotine replacement therapies (NRTs) and even conventional vaping products often lack the immediate nicotine hit, throat feel, and overall experience that smokers are accustomed to. T-MAX™ solves this problem by engineering a nicotine experience that closely mimics cigarette consumption without relying on flavours.T-MAX™ provides a unique 3-in-1 approach:1. The Speed of a Cigarette – Rapid nicotine delivery and rush within seconds for immediate satisfaction.2. The Power of Nicotine Salts – A stronger perceived nicotine effect without exceeding legal limits (20 mg/ml nicotine limit under the European Tobacco Products Directive). With T-MAX™, 8 mg/ml feels like 20 mg/ml, and 14 mg/ml feels like 40 mg/ml.3. The Throat Hit of Freebase Nicotine – Especially in a flavour-free formulation, the combined ingredients in T-MAX™ deliver an even more satisfying throat feel than expected from nicotine base, much closer to and more familiar with a cigarette throat feel that habitual smokers recognise.HIGHLIGHTS// unique 3-in-1 approach/ rush within seconds/ stronger perceived nicotine effect without exceeding legal limits/ more satisfying throat feel that habitual smokers recogniseNo flavour, but not less satisfyingWhile flavours have traditionally played a role in vaping adoption, market realities are shifting. With flavour bans spreading across regions, brands need solutions that deliver satisfaction without relying on taste. Consumer research has shown that T-MAX™ performs exceptionally well even without added flavours. Since most cigarette smokers do not smoke for the tobacco flavour but rather for the nicotine hit and habitual experience, T-MAX™ provides a viable alternative that aligns with new regulatory landscapes.HIGHLIGHTS// flavour bans spreading across regions/ T-MAX™ performs exceptionally well even without added flavoursEmpowering vape brands with free access to T-MAX™By granting customers royalty-free access to the T-MAX™ technology, Alchem NicSelect™ is removing barriers for vaping brands and original equipment manufacturers (OEMs) looking to adapt to regulatory changes. This open-access approach ensures that manufacturers can integrate T-MAX™ into their product lines without additional costs, allowing them to offer superior nicotine satisfaction in markets where flavours are no longer an option.HIGHLIGHTS// removing barriers for vaping brands and OEMs looking to adapt/ manufacturers can integrate T-MAX™ into product lines without additional costsThe future of vaping in restricted marketsWith T-MAX™, the vaping industry has a powerful tool to retain customers and convert smokers who have struggled with traditional vaping products. By delivering the key elements of cigarette satisfaction — without combustion or flavours — T-MAX™ is set to redefine what a satisfying vape experience means in a post-flavour-ban world.“Our commitment to innovation and accessibility means we are providing our customers with the solutions they need to navigate an evolving regulatory landscape. T-MAX™ allows brands to offer a highly satisfying experience that mimics smoking without relying on flavours. The message is clear: no flavour, but not less satisfying”, added Santambrogio.HIGHLIGHTS// powerful tool to retain customers and convert smokers/ delivering the key elements of cigarette satisfaction without combustion or flavours/ no flavour, but not less satisfying

    Impressions: 239

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets

    Radio Compass
    06 May 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaT-MAX™ 3-in-1 Formula: For Next-Gen E-LiquidsT-MAX™ 3-in-1 Formula: For Next-Gen E-Liquids

    T-MAX™ 3-in-1 Formula: For Next-Gen E-Liquids
    T-MAX™ 3-in-1 Formula: For Next-Gen E-Liquids

    reelT-MAX™ 3-in-1 Formula: For Next-Gen E-Liquids

    T-MAX™ by Alchem NicSelect™ — the patented nicotine formulation redefining satisfaction in flavour-restricted markets — is now available royalty-free to key customers. Experience the 3-in-1 nicotine satisfaction with speed, power, and throat hit, fully GMP-compliant and EU TPD-ready.

    Impressions: 546

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    Top Pharma Companies & Drugs in 2024: Merck’s Keytruda maintains top spot as Novo’s semaglutide nips at its heels

    Top Pharma Companies & Drugs in 2024: Merck’s Keytruda maintains top spot as Novo’s semaglutide nips at its heels

    In 2024, Big Pharma players consolidated and maintained their dominance, even as innovation continued to reshape the pharmaceutical landscape. The primary change last year was the meteoric rise of glucagon-like peptide-1 (GLP-1) receptor agonists that treat diabetes and help in weight loss.Amongst drugmakers, Pfizer retained its numero uno spot with an impressive US$ 63.6 billion in prescription drug sales (up 7 percent from US$ 59.56 billion reported in 2023), despite ever-shrinking Comirnaty sales, which settled at US$ 5.35 billion in 2024 (from US$ 11.22 billion in 2023).Merck secured the second position with revenues of US$ 57.4 billion, a growth of 7 percent over 2023. This performance was predominantly fueled by Keytruda, which now accounts for more than half of Merck’s total pharmaceutical revenue. Johnson & Johnson came a close third with US$ 57 billion in prescription drug sales (up from US$ 54.76 billion in 2023).AbbVie held the fourth position with US$ 56.33 billion in sales, achieving 3.7 percent growth despite the ongoing erosion of Humira revenue. This flagship immunology drug saw sales plummet 37.6 percent to approximately US$ 9 billion, a US$ 5.4 billion reduction compared to 2023. Humira’s loss was offset by AbbVie’s newer immunology assets, particularly Skyrizi and Rinvoq, both of which demonstrated exceptional growth trajectories. View Our Interactive Dashboard on Top Drugs in 2024 by Sales (Free Excel Available)European giants Astra, Roche, Novartis, Sanofi round out top 10 list; Novo, Lilly see astounding growthWhile the top four positions were dominated by American drugmakers, European giants dominated the lower half of the top 10 list.AstraZeneca secured the fifth spot with US$ 54.1 billion in sales, thereby posting impressive growth of 18.1 percent over 2023. Roche claimed the sixth position with US$ 50.9 billion in sales while Novartis ranked seventh — with sales of US$ 50.3 billion. Novartis' impressive 10.8 percent sales growth is attributed to its innovative medicines portfolio. Oncology therapies remained a cornerstone for both these Swiss drugmakers.Bristol Myers Squibb (BMS) secured eighth position with revenues of US$ 48.3 billion, representing 7.3 percent growth over the previous year. At US$ 45 billion, Eli Lilly posted 32 percent revenue growth last year. Its GLP-1 drug Mounjaro helped Lilly move up from the tenth in 2023 to the ninth spot last year.Sanofi landed the tenth position with US$ 42.6 billion in sales, propelled largely by the expanding indications of Dupixent. The French multinational has increasingly focused on this immunology blockbuster, while also garnering more sales from its vaccine and rare disease portfolios.Novo Nordisk merits a mention as it posted an incredible 26 percent year-on-year growth. It retained its eleventh spot with US$ 40.25 billion in sales. Novo’s growth was driven almost exclusively by the extraordinary success of its GLP-1 receptor agonist portfolio. View Our Interactive Dashboard on Top Drugs in 2024 by Sales (Free Excel Available)       Merck’s Keytruda retains throne with US$ 29.5 bn in sales, as Novo’s semaglutide nips at its heelsMoving on to drugs, Merck’s Keytruda (pembrolizumab) solidified its position as the world’s top-selling pharmaceutical product with sales exceeding US$ 29.5 billion and year-on-year growth of 17.88 percent (US$ 4.5 billion). This remarkable performance was driven by steady sales growth across more than 40 indications in the US. In 2024 alone, Keytruda secured four new approvals from the US Food and Drug Administration (FDA).However, Novo Nordisk’s semaglutide sales (Ozempic, Wegovy and Rybelsus) gave Keytruda a run for its money. Across the three blockbuster drugs, semaglutide earned the Danish drugmaker around US$ 28 billion — i.e. a year-on-year increase of 38 percent.Novo’s Ozempic (semaglutide) reached over US$ 16.7 billion in sales — a 20 percent increase from 2023. Originally approved in 2017 to improve glycemic control, Ozempic bagged additional approvals in 2020, and in January 2025. It is now approved to reduce the risk of major cardiovascular events, as well as to reduce cardiovascular risk and to lower the likelihood of chronic kidney disease in type 2 diabetes patients.Sales of Wegovy (semaglutide), the other blockbuster GLP-1 drug from Novo, grew by a whopping 85.7 percent to over US$ 8 billion.Sanofi and Regeneron’s Dupixent (dupilumab) secured the number three spot with sales of US$ 13.6 billion, representing an impressive 17.2 percent year-on-year growth. In 2024, Dupixent received three new approvals and one label update. Notably, it became the first-ever biologic medicine approved for patients with chronic obstructive pulmonary disease (COPD). View Our Interactive Dashboard on Top Drugs in 2024 by Sales (Free Excel Available) AbbVie’s post-Humira strategy pays off as Skyrizi surges 51%; Lilly’s Mounjaro posts 124% growthGilead Sciences’ HIV treatment Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) showed robust growth of 13.27 percent, touching sales of US$ 13.42 billion in 2024 and emerging as the fourth largest selling drug. Biktarvy now commands over 50 percent of the US HIV treatment market. Unlike many other drugs on this list, Biktarvy faces no immediate patent challenges, with key protections expected to remain intact until 2033.BMS and Pfizer’s anticoagulant Eliquis (apixaban) claimed the fifth position with US$ 13.33 billion in sales, representing a 9.21 percent year-on-year increase. AbbVie’s Skyrizi (risankizumab) emerged as one of the fastest-growing assets with a 50.95 percent year-on-year increase, generating US$ 11.71 billion in 2024 sales, thereby surpassing Humira’s (adalimumab) diminished sales.This impressive performance, combined with Rinvoq’s (upadacitinib) growth, has prompted  AbbVie to raise its long-term outlook for these products. The company now expects combined Skyrizi and Rinvoq revenues to exceed US$ 31 billion by 2027, with Skyrizi alone projected to generate over US$ 20 billion.Johnson & Johnson’s Darzalex (daratumumab) claimed the seventh position with US$ 11.67 billion in sales, representing 19.77 percent growth over 2023.Lilly’s Mounjaro (tirzepatide) demonstrated dramatic growth with sales increasing 123.51 percent to US$ 11.54 billion. This performance was complemented by Zepbound (tirzepatide, for weight loss), which contributed US$ 4.9 billion to Lilly’s revenue. By the end of 2024, Mounjaro received FDA approval for a new indication in obstructive sleep apnea (OSA), becoming the first and only prescription medicine for moderate-to-severe OSA in adults with obesity.Stelara (ustekinumab) ranked ninth, bringing J&J sales of US$ 10.36 billion, showing a modest decline of 4.91 percent from its 2023 sales.Vertex’s triple-combination therapy Trikafta (elexacaftor/tezacaftor/ivacaftor) for treating cystic fibrosis rounded out the top ten list with sales of US$ 10.2 billion, up 14 percent from the previous year. View Our Interactive Dashboard on Top Drugs in 2024 by Sales (Free Excel Available) Our viewIn 2024, transformative therapies like GLP-1 receptor agonists drove growth in the pharmaceutical industry. This year, we expect GLP-1 drugs to dethrone Keytruda from the number one spot. Along with novel immunology agents, we expect GLP-1 drugs to realign the pharmaceutical market.  
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 4095

    https://www.pharmacompass.com/radio-compass-blog/top-pharma-companies-drugs-in-2024-merck-s-keytruda-maintains-top-spot-as-novo-s-semaglutide-nips-at-its-heels

    #PharmaFlow by PHARMACOMPASS
    24 Apr 2025
    Share Share

    NEWS #PharmaBuzz

    [Sponsored by another company]read-more
    read-more
    Piramal Pharma Ltd. Invests $90M in Expansions at Two US Sites
    Piramal Pharma Ltd. Invests $90M in Expansions at Two US Sites

    12 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/piramal-pharma-ltd-continues-to-invest-in-usa-90m-in-expansions-of-two-us-sites-302452450.html

    PR NEWSWIRE
    12 May 2025
    Share Share
    Piramal Enterprises Faces $172M Tax Bill for Pharma Deal
    Piramal Enterprises Faces $172M Tax Bill for Pharma Deal

    03 Mar 2025

    // BUSINESS STD

    https://www.business-standard.com/companies/news/piramal-enterprises-hit-with-nearly-172-million-tax-bill-for-pharma-deal-125030100010_1.html

    BUSINESS STD
    03 Mar 2025
    Share Share
    Piramal declines after FDA issues Form 483 with 6 observations
    Piramal declines after FDA issues Form 483 with 6 observations

    20 Feb 2025

    // BUSINESS STD

    https://www.business-standard.com/markets/capital-market-news/piramal-pharma-declines-after-us-fda-issues-form-483-with-6-observations-to-turbhe-unit-125021900201_1.html

    BUSINESS STD
    20 Feb 2025
    Share Share
    Piramal Pharma Limited Announces Results for Q3 and 9M FY25
    Piramal Pharma Limited Announces Results for Q3 and 9M FY25

    29 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/piramal-pharma-limited-announces-results-for-q3-and-9m-fy25-302363138.html

    PR NEWSWIRE
    29 Jan 2025
    Share Share
    Piramal surges 4% after launching drug for psychiatric disorders
    Piramal surges 4% after launching drug for psychiatric disorders

    23 Jan 2025

    // BUSINESS STD

    https://www.business-standard.com/markets/news/piramal-pharma-surges-4-after-launching-drug-for-psychiatric-disorders-125012300441_1.html

    BUSINESS STD
    23 Jan 2025
    Share Share
    Piramal Pharma launches Chlorpromazine Hydrochloride in US
    Piramal Pharma launches Chlorpromazine Hydrochloride in US

    23 Jan 2025

    // BUSINESS STD

    https://www.business-standard.com/markets/capital-market-news/piramal-pharma-launches-chlorpromazine-hydrochloride-in-us-125012300245_1.html

    BUSINESS STD
    23 Jan 2025
    Share Share
    Contact Piramal Pharma Solutions and get a quotation

    Piramal Pharma Solutions is a supplier offers 118 products (APIs, Excipients or Intermediates).

    Find a price of Diltiazem Hydrochloride bulk with DMF, CEP, JDMF, WC offered by Piramal Pharma Solutions

    Find a price of Ketoconazole bulk with DMF, CEP, JDMF, WC offered by Piramal Pharma Solutions

    Find a price of Amiodarone Hydrochloride bulk with DMF, CEP, WC offered by Piramal Pharma Solutions

    Find a price of Aprepitant bulk with DMF, CEP, WC offered by Piramal Pharma Solutions

    Find a price of Baclofen bulk with DMF, CEP, WC offered by Piramal Pharma Solutions

    Find a price of Bisoprolol Fumarate bulk with DMF, CEP, WC offered by Piramal Pharma Solutions

    Find a price of Entacapone bulk with DMF, CEP, WC offered by Piramal Pharma Solutions

    Find a price of Fosaprepitant bulk with DMF, JDMF, WC offered by Piramal Pharma Solutions

    Find a price of Perindopril Erbumine bulk with DMF, CEP, WC offered by Piramal Pharma Solutions

    Find a price of Pramipexole Dihydrochloride bulk with DMF, CEP, WC offered by Piramal Pharma Solutions

    Find a price of Trazodone Hydrochloride bulk with DMF, CEP, WC offered by Piramal Pharma Solutions

    Find a price of Verapamil Hydrochloride bulk with DMF, CEP, WC offered by Piramal Pharma Solutions

    Find a price of Desmopressin Acetate bulk with DMF, CEP offered by Piramal Pharma Solutions

    Find a price of Leuprolide Acetate bulk with DMF, CEP offered by Piramal Pharma Solutions

    Find a price of Oxytocin bulk with DMF, CEP offered by Piramal Pharma Solutions

    Find a price of Aciclovir bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Armodafinil bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Brimonidine Tartrate bulk with CEP, WC offered by Piramal Pharma Solutions

    Find a price of Cinacalcet Hydrochloride bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Clobazam bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Dabigatran Etexilate Mesylate bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Deferasirox bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Donepezil bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Flecainide bulk with CEP, WC offered by Piramal Pharma Solutions

    Find a price of Levobunolol bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Lurasidone Hydrochloride bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Mebeverine bulk with CEP, WC offered by Piramal Pharma Solutions

    Find a price of Misoprostol bulk with DMF, CEP offered by Piramal Pharma Solutions

    Find a price of Oxybutynin Hydrochloride bulk with CEP, WC offered by Piramal Pharma Solutions

    Find a price of Paliperidone Palmitate bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Rivaroxaban bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Sulindac bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Tetrabenazine bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Tramadol Hydrochloride bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Valacyclovir Hydrochloride bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Buserelin Acetate bulk with CEP offered by Piramal Pharma Solutions

    Find a price of Calcitonin bulk with CEP offered by Piramal Pharma Solutions

    Find a price of Cetrorelix Acetate bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Somatostatin bulk with CEP offered by Piramal Pharma Solutions

    Find a price of Terlipressin Acetate bulk with CEP offered by Piramal Pharma Solutions

    Find a price of Abacavir Sulfate bulk with WC offered by Piramal Pharma Solutions

    Find a price of Anagrelide Hydrochloride bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Arginine Vasopressin bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Azilsartan bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Bexagliflozin bulk with WC offered by Piramal Pharma Solutions

    Find a price of Cloprostenol Sodium bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Dapagliflozin Propanediol Monohydrate bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Dexlansoprazole bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Diltiazem Hydrochloride bulk with CEP offered by Piramal Pharma Solutions

    Find a price of Dronedarone Hydrochloride bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Droxidopa bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Empagliflozin bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Gemfibrozil bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Halothane bulk with WC offered by Piramal Pharma Solutions

    Find a price of Ibuprofen bulk with CEP offered by Piramal Pharma Solutions

    Find a price of Irbesartan bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Isoflurane bulk with WC offered by Piramal Pharma Solutions

    Find a price of Levoketoconazole bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Metaxalone bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Mirabegron bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Octreotide Acetate bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Octreotide Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Oxytocin bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Pregabalin bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Quetiapine Hemifumarate bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Tafenoquine Succinate bulk with WC offered by Piramal Pharma Solutions

    Find a price of Tolcapone bulk with WC offered by Piramal Pharma Solutions

    Find a price of Varenicline Tartrate bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Verapamil Hydrochloride bulk with CEP offered by Piramal Pharma Solutions

    Find a price of Vortioxetine Hydrobromide bulk with DMF offered by Piramal Pharma Solutions

    Find a price of EDOXABAN TOSYLATE MONOHYDRATE bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Bexagliflozin bulk offered by Piramal Pharma Solutions

    Find a price of Carbetocin Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Gonadorelin Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Spironolactone bulk offered by Piramal Pharma Solutions

    Find a price of Tetracosactide bulk offered by Piramal Pharma Solutions

    Find a price of Abaloparatide Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Apixaban bulk offered by Piramal Pharma Solutions

    Find a price of Apremilast bulk offered by Piramal Pharma Solutions

    Find a price of Arginine Vasopressin bulk offered by Piramal Pharma Solutions

    Find a price of Atosiban bulk offered by Piramal Pharma Solutions

    Find a price of Cabozantinib bulk offered by Piramal Pharma Solutions

    Find a price of Camylofin Dihydrochloride bulk offered by Piramal Pharma Solutions

    Find a price of Canagliflozin bulk offered by Piramal Pharma Solutions

    Find a price of Carmustine bulk offered by Piramal Pharma Solutions

    Find a price of Cetrorelix Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Corticotropin bulk offered by Piramal Pharma Solutions

    Find a price of Degarelix Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Desmopressin Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Desvenlafaxine Succinate bulk offered by Piramal Pharma Solutions

    Find a price of Edoxaban Tosylate bulk offered by Piramal Pharma Solutions

    Find a price of Eluxadoline bulk offered by Piramal Pharma Solutions

    Find a price of Glatiramer Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Glucagon bulk offered by Piramal Pharma Solutions

    Find a price of Goserelin Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Lanreotide Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Lercanidipine bulk offered by Piramal Pharma Solutions

    Find a price of Leuprolide Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Linaclotide bulk offered by Piramal Pharma Solutions

    Find a price of Linagliptin bulk offered by Piramal Pharma Solutions

    Find a price of Liraglutide bulk offered by Piramal Pharma Solutions

    Find a price of Mecamylamine Hydrochloride bulk offered by Piramal Pharma Solutions

    Find a price of Oxytocin bulk offered by Piramal Pharma Solutions

    Find a price of Paliperidone bulk offered by Piramal Pharma Solutions

    Find a price of Plecanatide bulk offered by Piramal Pharma Solutions

    Find a price of Rimegepant Sulfate bulk offered by Piramal Pharma Solutions

    Find a price of Semaglutide bulk offered by Piramal Pharma Solutions

    Find a price of Succimer bulk offered by Piramal Pharma Solutions

    Find a price of Sugammadex Sodium bulk offered by Piramal Pharma Solutions

    Find a price of Sulfiram bulk offered by Piramal Pharma Solutions

    Find a price of Tafenoquine bulk offered by Piramal Pharma Solutions

    Find a price of Teduglutide bulk offered by Piramal Pharma Solutions

    Find a price of Terlipressin Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Trientine Hydrochloride bulk offered by Piramal Pharma Solutions

    Find a price of Triptorelin Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Valacyclovir bulk offered by Piramal Pharma Solutions

    Find a price of Vibegron bulk offered by Piramal Pharma Solutions

    Find a price of RABACFOSADINE SUCCINATE bulk offered by Piramal Pharma Solutions